Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
Susan Smith(Waitemata District Health Board), Javier Cote-Sierra(Research Triangle Park Foundation), Jessica Neil(Research Triangle Park Foundation), Edwige Nicodème(GlaxoSmithKline (France)), Sylvia M. Furst(Research Triangle Park Foundation), David J. Rickard(GlaxoSmithKline (United States)), Deepak K. Rajpal(Research Triangle Park Foundation), Christine M. Coquery(Research Triangle Park Foundation), Dalei Wu(Shandong University), John T. Moore(Research Triangle Park Foundation), Channa Jayawickreme(Research Triangle Park Foundation), Cathy Simmons(Research Triangle Park Foundation), Fabrice Viviani(GlaxoSmithKline (France)), Katrina L. Creech(Research Triangle Park Foundation), Fraydoon Rastinejad(Jenner Institute), Timothy M. Willson(University of North Carolina at Chapel Hill), James Lee(Royal Free London NHS Foundation Trust), Thi Tho Bui(Research Triangle Park Foundation), William M. Pryor(Research Triangle Park Foundation), David Mayhew(GlaxoSmithKline (United States)), David C. Morris(Research Triangle Park Foundation)
Cited by 366
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k